Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- 30 Day Readmission (1)
- 30-day Readmissions (1)
- Aortic regurgitation (1)
- Aortic stenosis (1)
- Cardiac Arrhythmia (1)
-
- Cost (1)
- Diabetes (1)
- Foreign born (1)
- Health Expenditure (1)
- Health Service Expenditure (1)
- Health Service Utilization (1)
- High Cholesterol Levels (1)
- Hypertension (1)
- Metabolic Diseases (1)
- National Readmission Database (1)
- Readmission (1)
- Surgical aortic valve replacement (1)
- Transcatheter aortic valve replacement (1)
Articles 1 - 2 of 2
Full-Text Articles in Cardiovascular Diseases
Health Service Utilization And Expenditure In Cardio-Metabolic Conditions In The United States Adults, Kavita Mosalpuria
Health Service Utilization And Expenditure In Cardio-Metabolic Conditions In The United States Adults, Kavita Mosalpuria
Theses & Dissertations
Metabolic syndrome is multicomponent risk factor for cardiovascular diseases (CVD) and type 2 diabetes that reflects the clustering of at least 3 cardiometabolic risk factors, among hypertension, impaired glucose regulations, hypercholesterolemia, and obesity. CVD are the leading cause of death in the U.S. CVD occur at earlier age and is a major cause of death and disability among people with diabetes. As compared to Japan, 13.3% to 44% of the excess CVD mortality in the U.S. can be explained by the metabolic syndrome. The prevalence of metabolic syndrome was 34.3% in 2007 to 2014 and it increases with age. Metabolic …
The Evolving Management Of Aortic Valve Disease: Trends In The Utilization And Cost Of Savr, Tavr, And Medical Therapy, Andrew Goldsweig
The Evolving Management Of Aortic Valve Disease: Trends In The Utilization And Cost Of Savr, Tavr, And Medical Therapy, Andrew Goldsweig
Theses & Dissertations
Aortic stenosis (AS) and regurgitation (AR) may be treated with surgical aortic valve replacement (SAVR), transcatheter AVR (TAVR), or medical therapy (MT). Data are lacking regarding usage and cost of SAVR, TAVR, and MT for patients hospitalized with aortic valve disease. From the Nationwide Readmissions Database, we determined utilization and cost trends for SAVR, TAVR, and MT in patients with aortic valve disease admitted 2012-2016 for valve replacement, heart failure, unstable angina, non-ST-elevation myocardial infarction, or syncope. From 2012 through 2016, there was a 48.1% increase in the number of patients hospitalized for aortic valve disease annually. Overall, 19.9%, 6.7%, …